Live data · NADAC + Part D CY24 · reviewed daily

Bismuth Subcitrate Potassium, Metronidazole and Tetracycline

Nitroimidazole Antimicrobial class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2023-03-07
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$2.40/unit
1 NDCs benchmarked, lowest of all strengths.
Average NADAC
$2.40
Across all dosage forms in distribution.
Highest NADAC
$2.40
Range is tight.
Plans with PA
0 / 329
Zero PA friction across surveyed plans.

Questions a plan sponsor actually asks.

FAQPage schema6 entries indexed · 4 visible
What is Bismuth Subcitrate Potassium, Metronidazole and Tetracycline used for?

Bismuth Subcitrate Potassium, Metronidazole and Tetracycline is tracked in Medicare Part D. Specific indication information is not available in our current dataset.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book
Is there a generic for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline?

No. Bismuth Subcitrate Potassium, Metronidazole and Tetracycline is brand-only with no generic equivalents currently in market.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book
How much does my plan pay for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline?

Across 329 Part D plans, Bismuth Subcitrate Potassium, Metronidazole and Tetracycline averages $2.40/unit (NADAC). Lowest available: $2.40/unit. Highest in distribution: $2.40/unit.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book
Is Bismuth Subcitrate Potassium, Metronidazole and Tetracycline on the FDA shortage list?

No. Bismuth Subcitrate Potassium, Metronidazole and Tetracycline is not currently on the FDA Drug Shortage Database.

Sources: CMS Part D Spending CY24 · CMS NADAC weekly · FDA Orange Book

2 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Related questions.

Q&A librarySourced · reviewed quarterly
pricingWhat is NADAC?pricingIs NADAC the same as my PBM cost?pricingWhat is spread pricing?pricingWhat is a NADAC pass-through PBM contract?pricingWhat's the difference between AWP, MAC, and NADAC?pricingWhat is a dispensing fee in a PBM contract?
Browse all canonical questions →

Sources · every number above traces back.

Last refresh15 Oct 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.